Pharmacology of caffeinol in embolized rabbits: Clinical rating scores and intracerebral hemorrhage incidence

Experimental Neurology

Volumn 188, Issue 2, 2004, Pages 286-291

  Lapchak, Paul A ^a,b,c   Song, Donghuan ^b,c   Wei, Jiandong ^b,c   Zivin, Justin A ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alteplase; Ischemia; Neuroprotection; Reperfusion; Thrombolytic; tPA

Indexed keywords

ALCOHOL; CAFFEINE; NEUROPROTECTIVE AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CIRCULATION; BRAIN EMBOLISM; BRAIN HEMORRHAGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; LOW DRUG DOSE; MALE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ETHANOL; FIBRINOLYTIC AGENTS; INCIDENCE; INFUSIONS, INTRAVENOUS; INJECTIONS; INTRACRANIAL EMBOLISM; MALE; MICROSPHERES; NEUROPROTECTIVE AGENTS; RABBITS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT FAILURE;

EID: 3042828639     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.03.003     Document Type: Article

References (24)

1. Altura B.M., Gebrewold A., Zhang A., Altura B.T. Role of leukocytes in ethanol-induced microvascular injury in the rat brain in situ: potential role in alcohol brain pathology and stroke. Eur. J. Pharmacol. 448:2002;89-94
2. Altura B.M., Gebrewold A., Zhang A., Altura B.T. Ethanol induces rapid lipid peroxidation and activation of nuclear factor-kappa B in cerebral vascular smooth muscle: relation to alcohol-induced brain injury in rats. Neurosci. Lett. 325:2002;95-98
3. Aronowski J., Strong R., Shirzadi A., Grotta J.C. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience. Stroke. 34:2003;1246-1251
4. Evans S.M., Pinto Pereira L.M., Addae J.I. Neuroprotection by caffeine and pentoxifylline during experimental cerebral ischaemia. West Indian Med. J. 48:1999;23-25
5. Fadda F., Rossetti Z.L. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog. Neurobiol. 56:1998;385-431
6. Kang S.H., Lee Y.A., Won S.J., Rhee K.H., Gwag B.J. Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures. NeuroReport. 13:2002;1945-1950
7. Kubota M., Yamaura A., Ono J. Prevalence of risk factors for aneurysmal subarachnoid haemorrhage: results of a Japanese multicentre case control study for stroke. Br. J. Neurosurg. 15:2001;474-478
8. Kuribara H. Enhancement of the behavioral toxicity induced by combined administration of ethanol with methylxanthines: evaluation by discrete avoidance in mice. J. Toxicol. Sci. 18:1993;95-101
9. Lancaster F.E. Alcohol, nitric oxide, and neurotoxicity: is there a connection? - A review. Alcohol. Clin. Exp. Res. 16:1992;539-541
10. Lapchak P.A. Development of thrombolytic therapy for stroke: a perspective. Expert Opin. Investig. Drugs. 11:2002;1623-1632
11. Lapchak P.A., Zivin J.A. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits. Synergism with low-dose tissue plasminogen activator. Stroke. 34:2003;2013-2018
12. Lapchak P.A., Chapman D.F., Zivin J.A. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke. 31:2000;3034-3040
13. Lapchak P.A., Chapman D.F., Zivin J.A. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2, 2, 6, 6- tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke. 32:2001;147-153
14. Lapchak P.A., Araujo D.M., Pakola S., Song D., Wei J., Zivin J.A. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke. 33:2002;2279-2284
15. Lapchak P.A., Araujo D.M., Song D., Wei J., Zivin J.A. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1, 3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke. 33:2002;1411-1415
16. Mandel H.G. Update on caffeine consumption, disposition and action. Food Chem. Toxicol. 40:2002;1231-1234
17. Marks V. Clinical pathology of alcohol. J. Clin. Pathol. 36:1983;365-378
18. Morgan P.F., Durcan M.J. Caffeine-induced seizures: apparent proconvulsant action of N-ethyl carboxamidoadenosine (NECA). Life Sci. 47:1990;1-8
19. Piriyawat P., Labiche L.A., Burgin W.S., Aronowski J.A., Grotta J.C. Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke. Stroke. 34:2003;1242-1245
20. Puddey I.B., Croft K.D., Abdu-Amsha Caccetta R., Beilin L.J. Alcohol, free radicals and antioxidants. Novartis Found. Symp. 216:1998;51-62. (discussion 63-67, 152-158)
21. Shapira Y., Lam A.M., Paez A., Artru A.A., Laohaprasit V., Donato T. The influence of acute and chronic alcohol treatment on brain edema, cerebral infarct volume and neurological outcome following experimental head trauma in rats. J. Neurosurg. Anesthesiol. 9:1997;118-127
22. Strong R., Grotta J.C., Aronowski J. Combination of low dose ethanol and caffeine protects brain from damage produced by focal ischemia in rats. Neuropharmacology. 39:2000;515-522
23. Zhang A., Altura B.T., Altura B.M. Ethanol-induced contraction of cerebral arteries in diverse mammals and its mechanism of action. Eur. J. Pharmacol. 248:1993;229-236
24. Zivin J.A. Thrombolytic stroke therapy: past, present, and future. Neurology. 53:1999;14-19